Company Description

Topos is building an AI-native drug discovery platform for intrinsically disordered proteins -- dynamic proteins implicated in diseases like Alzheimer's and prostate cancer. Their approach models protein ensembles rather than single static structures, unlocking previously "undruggable" targets.